BAL,Npat estimates., page-25

$25.6m in H1 + 30% improvement in sales ($8m) + no stock write off ($14m) implies H2 PAT will be $47.6m.  Way too optimistic.
So you are saying FY19 PAT of $73.2m or BAL is valued at 13 times earnings, dream.

Prove your false stats.  What was last year's PAT?

Now consider my estimate with similar logic.
$12m in H1 + 30% improvement in H2 ($8m) + no stock write off ($14m) implies H2 PAT will be $34m.
I am saying FY19 PAT of $48m, roughly in line with FY18.

Please validate your wild estimates.